Upper GIs: Investigating the Self-Care Market for Upper Gastrointestinals
Reports Library Publication

Upper GIs: Investigating the Self-Care Market for Upper Gastrointestinals

21st December 2017 by Nicholas Hall Reports

Download Brochure Detailed Breakdown Sample Pages

Upper GIs

Until 31 December, we are offering a 15% discount on the 2018 Reports Catalogue, plus an additional 10% discount on orders for multiple reports.

Take 15% off the listed price for this report, or 25% off when purchasing multiple reports. 

This report is an in-depth exploration of the Upper Gastrointestinals market, including antacids, antiflatulents, antinauseants, digestive enzymes and liver & bile remedies and includes coverage of 15 major markets from across the globe, with topline sales, brand performances, regulatory developments, launches and ad campaigns.

With mid-year sales from DB6 2017, data includes topline historical sales for region, country and category, plus individual brand performances and forecasts to 2021 and 2026 for all categories and countries, plus a look ahead at what the future holds for the Upper GIs market globally.

The report also includes: an in-depth look at the latest scientific studies and case studies of key brands, highlighting success factors, sales, NPD and advertising activity.

Order this report

This report is an in-depth exploration of the Upper Gastrointestinals market, including antacids, antiflatulents, antinauseants, digestive enzymes and liver & bile remedies and includes coverage of 15 major markets from across the globe, with topline sales, brand performances, new developments, launches and A+P campaigns.

Upper GIs: Investigating the Self-Care Market for Upper Gastrointestinals

Why buy this report?

"PPI switches gave the Upper GIs market a new lease of life in recent years, while traditional antacids saw a resurgence thanks to their strong consumer heritage. Our in-depth report examines the market for antacids – plus antiflatulents, antinauseants, digestive enzymes and liver & bile remedies – in 15 major countries around the globe."

Nicholas Hall

Contact us here

All personal data herein are processed in accordance with UK data protection legislation. All feasible security measures are in place.